Lu, Guojin – Trademark Portfolio
Entity Type: 01
Lu, Guojin owns a portfolio of 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CKTY, CSJK, CTGY, ANDUG, and COGOD. Of these, 20 are registered. The portfolio spans 6 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 18 (Leather Goods). Headquartered in Dali, Yunnan.
Yongcui Town, Nanrun Yizu County
No.64,Xinshan Vill., No.2,Anli Cunweihui
Dali, Yunnan 671000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Lu, Guojin's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Lu, Guojin have?
Lu, Guojin has 21 U.S. trademarks filed with the USPTO. Of these, 20 registered, 1 abandoned.
What trademark classes does Lu, Guojin file in?
Lu, Guojin files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 18 (Leather Goods), Class 16 (Paper Goods), Class 10 (Medical Apparatus), Class 24 (Fabrics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Lu, Guojin's most well-known trademarks?
Lu, Guojin's registered trademark portfolio includes well-known marks such as CKTY, CSJK, CTGY, ANDUG, and COGOD. These are among 20 currently registered trademarks in the portfolio.
What is Lu, Guojin's trademark registration success rate?
Lu, Guojin has a 95% trademark registration rate, with 20 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.